Carotid atherosclerosis severity in relation to glycemic status: A cross-sectional population study

Atherosclerosis

Volumn 242, Issue 2, 2015, Pages 377-382

  Mostaza, Jose M ^a   Lahoz, Carlos ^a   Salinero Fort, Miguel A ^b   de Burgos Lunar, Carmen ^a   Laguna, Fernando ^a   Estirado, Eva ^a   García Iglesias, Francisca ^a   González Alegre, Teresa ^a   Cornejo Del Río, Víctor ^a   Sabín, Concesa ^a   López, Silvia ^a   Linde, Aguilera ^c   De Carcer Escolano, Álvaro R Aguirre ^d   Sacristán, Patricio Alonso ^c   Álvarez Otero, M Jesús ^e   Pérez, Paloma Arribas ^f   Ruiz, Maria Luisa Asensio ^g   Díaz, Pablo Astorga ^h   Ena, Begoña Berriatua ^e   Varela, Ana Isabel Bezos ⁱ   Triguero, María José Calatrava ^j   García, Carlos Casanova ^h   Llorente, Ángeles Conde ^h   Laso, Diaz ^g   García, Emilia Elviro ^c   Dueñas, Orlando Enríquez ^g   Zapata, María Isabel Ferrer ^k   Antuña, Froilán ^c   Lazaro, Maria Isabel García ^c   Rodríguez, Maria Teresa Gómez ^h   Lucena, África Gómez ^d   Hernández, Francisco Herrero ^d   Viñals, Rosa Julián ^e   Ogarrio, Gerardo López Ruiz ^h   Manzano, Maria Del Carmen Lumbreras ⁱ   López, Sonsoles Paloma Luquero ^c   Peláez, Ana Martinez Cabrera ^h   Candenas, Montserrat Nieto ^d   Carrera, María Alejandra Rabanal ^h   Rodríguez, Ángel Castellanos ^c   Castellanos, Ana López ^d   García, Milagros Velazquez ^h   Pacheco, Margarita Ruiz ^e   more..

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Serv Madrileño de Salud Inst de Invest Sanitaria del Hospital Universitario la Paz IdiPaz   (Spain)

^c Cs Ciudad Periodistas   (Spain)

^d CS Ventilla   (Spain)

^e Cs Ciudad Periodistas ^*  (Spain)

^f Cs Santa Hortensia   (Spain)

^g Cs Fuentelarreina   (Spain)

^h Cs Barrio Pilar   (Spain)

ⁱ Cs Jose Marva   (Spain)

^j Cs Ciudad Jardín   (Spain)

^k CS El Greco   (Spain)

more..

Author keywords

Carotid atherosclerosis; Carotid plaques; Diabetes mellitus type 2; Intima media thickness; Prediabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DOPPLER ECHO; FEMALE; GLYCEMIC INDEX; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; STENOSIS; AGED; ANALYSIS; CAROTID ARTERY DISEASES; COMPLICATION; DIABETES COMPLICATIONS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MASS SCREENING; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; PREDIABETIC STATE; RISK FACTOR; SPAIN;

AGED; BLOOD GLUCOSE; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PREDIABETIC STATE; PREVALENCE; RISK FACTORS; SPAIN;

EID: 84939157513     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.07.028     Document Type: Article

References (28)

1. Shah A.D., Langenberg C., Rapsomaniki E., et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2014, 3:105-113.
2. Colagiuri S. Epidemiology of prediabetes. Med. Clin. North Am. 2011, 95:299-307.
3. DeFronzo R.A., Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol. 2011, 108:3B-24B.
4. Morris D.H., Khunti K., Achana F., et al. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 2013, 56:1489-1493.
5. Marini M.A., Succurro E., Castaldo E., et al. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012, 35:1144-1149.
6. Di Pino A., Scicali R., Calanna S., et al. Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria. Diabetes Care 2014, 37:1447-1453.
7. Bobbert T., Mai K., Fischer-Rosinsky A., Pfeiffer A.F.H., Spranger J. A1C is associated with intima-media thickness in individuals with normal glucose tolerance. Diabetes Care 2010, 33:203-204.
8. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
9. Reiner Ž., Catapano A.L., De Backer G., et al. ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 2011, 32:1769-1818.
10. Grundy S.M., Arai H., Barter P., et al. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia - full report. J. Clin. Lipidol. 2014, 8:29-60.
11. Polak J.F., Szklo M., Kronmal R.A., et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J. Am. Heart Assoc. 2013, 2:e000087.
12. Ataoglu H.E., Saler T., Uzunhasan I., et al. Additional value of carotid artery intima-media thickness in cardiovascular risk assessment by Framingham risk-score in Type 2 diabetes: a retrospective cohort study. J. Diabetes 2009, 1:188-193.
13. Inaba Y., Chen J.A., Bergmann S.R. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012, 220:128-133.
14. Wagenknecht L.E., D'Agostino R.B., Haffner S.M., Savage P.J., Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the insulin resistance atherosclerosis study. Diabetes Care 1998, 21:1812-1818.
15. Grant E.G., Benson C.B., Moneta G.L., et al. Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis-society of radiologists in ultrasound consensus conference. Ultrasound Q. 2003, 19:190-198.
16. Association AD Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29:43-48.
17. Mosca A., Goodall I., Hoshino T., et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC working group. Clin. Chem. Lab. Med. 2007, 45:1077-1080.
18. Glucose tolerance and mortality: comparison of WHO and American diabetes association diagnostic criteria. The DECODE study group. European diabetes epidemiology group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999, 354:617-621.
19. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 2010, 362:800-811.
20. Park S., Barrett-Connor E., Wingard D.L., Shan J., Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 1996, 19:450-456.
21. Brohall G., Odén A., Fagerberg B. Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet. Med. 2006, 23:609-616.
22. Brohall G., Schmidt C., Behre C.J., Hulthe J., Wikstrand J., Fagerberg B. Association between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysis. Nutr. Metab. Cardiovasc Dis. 2009, 19:327-333.
23. Xing F.Y.F., Neeland I.J., Gore M.O., et al. Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study. Diab Vasc. Dis. Res. 2014, 11:11-18.
24. Sacco R.L. Identifying patient populations at high risk for stroke. Neurology 1998, 51(Suppl. 3):S27-S30.
25. Screening for carotid artery stenosis: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 2014, 161:356-362.
26. Faerch K., Vistisen D., Johansen N.B., Jorgensen M.E. Cardiovascular risk stratification and management in pre-diabetes. Curr. Diabetes Rep. 2014, 14:493-500.
27. Kohli P., Waters D.D., Nemr R., et al. Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics. J. Am. Coll. Cardiol. 2015, 65:402-404.
28. Ridker P.M., Pradhan A., MacFadyen J.G., Libby P., Glynn R.J. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 2012, 11(380):565-571.